Business
Research Reports Initiated on Healthcare Stocks Aphria, Antibe Therapeutics, BriaCell Therapeutics, and IntelGenx Technologies
LONDON, UK / ACCESSWIRE / March 7, 2017 / Active Wall St. announces the list of stocks for t...
About this update from Briacell Therapeutics Corp
[{"type":"text","content":"Research Reports Initiated on Healthcare Stocks Aphria, Antibe Therapeutics, BriaCell Therapeutics, and IntelGenx TechnologiesLONDON, UK / ACCESSWIRE / March 7, 2017 / Active Wall St. announces the list of stocks for today’s research reports. Pre-market the Active Wall St. team provides the technical coverage impacting selected stocks trading on the Toronto Exchange and belonging under the Biotechnology industry. Companies recently under review include Aphria, Antibe Therapeutics, BriaCell Therapeutics, and IntelGenx Technologies. Get all of our free research reports by signing up at:\n \nhttp://www.activewallst.com/register/ \n \nOn Monday, March 06, 2017, The TSX Venture Composite Index, on the other hand, closed at 810.25, down 1.00%.\n \nThe Healthcare Index was also in the red, closing the day at 70.92, down 1.94%.\n \nActive Wall St. has initiated research reports on the following equities: Aphria Inc. (TSX-V: APH), Antibe Therapeutics Inc. (TSX-V: ATE), BriaCell Therapeutics Corporation (TSX-V: BCT), and IntelGenx Technologies Corporation (TSX-V: IGX). Register with us now for your free membership and research reports at:\nhttp://www.activewallst.com/register/\nAphria Inc.\n \nLeamington, Canada headquartered Aphria Inc.'s stock advanced 2.20%, to finish Monday's session at $6.97 with a total volume of 1.25 million shares traded. Over the last one month and the previous three months, Aphria's shares have surged 29.07% and 33.27%, respectively. Further, the stock has rallied 500.86% in the past one year. The Company’s shares are trading above its 50-day and 200-day moving averages. Aphria’s 50-day moving average of $5.86 is above its 200-day moving average of $4.54. Shares of the Company, which produces, supplies, and sells medical cannabis in Canada, are trading at a PE ratio of 165.95. See our research report on APH.V at:\nhttp://www.activewallst.com/register/ \nAntibe Therapeutics Inc.\n \nOn Monday, shares in Toronto, Canada headquartered Antibe Therapeutics Inc. recorded a trading volume of 6,950 shares. The stock ended the day 4.88% higher at $0.22. Antibe Therapeutics’ stock has gained 19.44% in the last three months and 48.28% in the previous one year. Shares of the Company, which originates, develops, and out-licenses patent protected pharmaceuticals, are trading above its 50-day and 20...